Danish drugmaker Novo Nordisk is betting on its insulin leadership in India to dominate the country's $25-billion anti-obesity drug market with the imminent launch of its weight-loss therapy, a ...

Tirzepatide reduces breast tumor growth in obese mice while improving metabolic health, offering hope as a dual-action cancer ...

Generic drugmaker Viatris has become the first company to secure FDA approval for a biosimilar product that is considered completely interchangeable with the reference product – namely Sanofi's ...

Oprah Winfrey and Elon Musk endorsed it. And though Indian celebrities haven’t yet admitted to their use, the mystery slimming of Bollywood filmmaker Karan Johar and TV talk show host Kapil Sharma ...

The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products. Ben Hargreaves looks at why insulin’s ...

Erythritol, a low-calorie sugar substitute, may be associated with increased heart attack and stroke risk, according to a new ...

In this 2025 public health alignment update, GlucoTru Pro emphasizes the growing consumer awareness of natural metabolic ...

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building an ...

Digging Into HepatoBurn Reviews, Ingredients, Side Effects & Why This Liver-Focused Metabolism Formula Is Dominating 2025 ...

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan Skrmetti.

Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...

The participants in the trial – similar to two-thirds of breast cancer patients overall - had tumors that use the hormones ...